Established in 2007, Xian New Drug Evaluation Research Center XDER is a contract research organization offering integrated preclinical services to the biotechnology pharmaceutical industries, including 1 P III laboratory services, 2 Radioactive compounds DMPK Whole-body Autoradiography, 3DSI System.
Housed in the 50,000 sq. ft, state-of-the-art facility, XDER is in full compliance with SFDA GLP requirements. XDER seeks to provide an instrumental basis for drug discovery an insight into designing in vivo efficacy studies. It utilizes cutting-age equipments work closely